Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Statement re Suspension and Potential Transaction

8 Jun 2012 07:30

RNS Number : 9497E
Vipera PLC
08 June 2012
 

 

For release on Friday 8 June 2012, 0730 hrs

 

 

VIPERA PLC

("VIPERA" or "THE COMPANY")

Statement re Suspension

and

Potential Reverse Transaction

 

Vipera, the specialist provider of mobile financial software services, announces that after a lengthy period of negotiation, the Company has agreed non-binding terms for a significant transaction with a company whose business is complementary to that of Vipera's (the "Transaction"). This Transaction will constitute a reverse take-over under the AIM Rules. In the light of work undertaken on this Transaction, the Company has concluded that it will not be in a position to publish its Report and Accounts for the year ended 31 December 2011 within the deadline required under the AIM Rules, 30 June 2012, and accordingly trading in the Company's shares is suspended with immediate effect. The suspension will remain pending the publication of the Accounts and, if the Transaction proceeds, the Admission Document.

 

The results for the year ended 31 December 2011 are likely to be in line with the announcement made on 26 October, 2011.

 

Since the year-end, considerable resources and management time have been expended in pursuit of the opportunity set out above, with the target being a profitable and fast-growing business with clear strategic synergies with Vipera's existing offering. The Company is now looking to raise additional capital both in relation to the above Transaction and in relation to its own development.

 

Wider economic conditions continue to make the process for closing sales in the banking markets longer than previously experienced. However, the Company announces that it has recently concluded its largest sale to date, to a company in Italy, outside the banking sector, that is anticipated will contribute revenues of £1.5million over three years.

 

Marco Casartelli, Vipera Chief Executive, said "I am looking forward to progressing this transaction and to being in a position to inform shareholders about what we believe is a very exciting opportunity."

 

 

-Ends-

 

Vipera PLC

Marco Casartelli

Tel: +39 02 7214 2424

Roger Mitchell

Tel: +39 02 7214 2424

Martin Perrin

Tel: +44 (0) 7785 505 337

Beaumont Cornish Limited (Nomad)

Tel: +44 (0) 20 7628 3396

Roland Cornish

Felicity Geidt

Media Enquiries

Hudson Sandler

Charlie Jack / George Parker

 

Tel: + 44 (0) 20 7796 4133

 

Notes to Editors

Vipera is an international mobile commerce provider with a focus on the Middle Eastern market, where it has established itself as the preferred partner of national banks and global technology businesses.

 

Vipera provides software and services to banks and financial institutions to enable mobile access to personal financial services. Additionally Vipera's software enables Government and corporate entities to allow their services and consumer transactions to take place on mobile platforms.

 

Vipera is ideally placed to leverage its significant success to date and seize further share of this market, buoyed by the growth of smart phones, forecast by 2013 to grow to 977 million users and in revenue from $71bn to $862 billion.

 

Vipera's headquarters are in Milan and it listed on the London Stock Exchange (AIM: VIP.L). For further information, please visit www.vipera.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREAXKXESDAEFF
Date   Source Headline
20th Dec 20247:00 amRNSTransaction in Own Shares
26th Nov 202411:29 amRNSHalf-year Report - Replacement
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20245:14 pmRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20245:19 pmRNSTransaction in Own Shares
18th Nov 20244:57 pmRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20245:05 pmRNSTransaction in Own Shares
12th Nov 20245:49 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20245:13 pmRNSTransaction in Own Shares
15th Oct 20245:21 pmRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20244:55 pmRNSTransaction in Own Shares
7th Oct 20245:18 pmRNSTransaction in Own Shares
3rd Oct 202410:31 amRNSStatement re MAR
3rd Oct 202410:08 amRNSPortfolio Update and Half Year End Valuation
18th Sep 20249:38 amRNSDividend Declaration
9th Sep 20247:00 amRNSChange of AIFM
23rd Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 20243:22 pmRNSDirectorate Change
11th Jul 20241:13 pmRNSResult of AGM
20th Jun 20245:37 pmRNSTransaction in Own Shares
12th Jun 20247:00 amRNSAnnual Financial Report
29th Apr 20244:58 pmRNSTransaction in Own Shares
25th Apr 20245:01 pmRNSTransaction in Own Shares
24th Apr 20245:24 pmRNSTransaction in Own Shares - Replacement
24th Apr 20245:11 pmRNSTransaction in Own Shares
23rd Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 20244:56 pmRNSTransaction in Own Shares
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20245:13 pmRNSTransaction in Own Shares
4th Apr 20244:59 pmRNSTransaction in Own Shares
4th Apr 202411:39 amRNSStatement re MAR
2nd Apr 20247:00 amRNSAcquisitions and Year End Portfolio Valuation
19th Mar 20245:01 pmRNSTransaction in Own Shares
18th Mar 20244:49 pmRNSTransaction in Own Shares
14th Mar 20244:54 pmRNSTransaction in Own Shares
11th Mar 20245:06 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:49 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDividend Declaration
6th Feb 20245:01 pmRNSTransaction in Own Shares
22nd Dec 202312:26 pmRNSHolding(s) in Company
21st Dec 20234:30 pmRNSDirector/PDMR Shareholding
20th Dec 202311:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.